🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Verification of Risk Factors of Thrombohemorrhagic Complications in Recipients After Related Liver Transplantation

Recruitingn/aAges 18 Years - 70 YearsAllRepublican Specialized Scientific and Practical M…
NCT06169592 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The aim of the study is to improve the results of related transplantation of the right liver lobe by verifying the general predictors of the development of hemostatic system disorders and optimizing a comprehensive program for thrombohemorrhagic complications preventing.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age over 18 years and up to 70 years; * Signed informed consent for inclusion to the study; * End stage liver cirrhosis. Exclusion Criteria: * Pregnancy; * Extrahepatic factors influencing systemic hemostasis; * Concomitant hematological diseases affecting the hemostatic system; * Severe concomitant disorders.
💊

What it tests

  • Liver transplantation
📍

Where

1 site
Republican specialized scientific and practical medical center of surgery named after academician V.Vakhidov
Tashkent, Uzbekistan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy